Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy
Owen, C.N., Shoushtari, A.N., Chauhan, D., Palmieri, D.J., Lee, B., Rohaan, M.W., Mangana, J., Atkinson, V., Zaman, F., Young, A., Hoeller, C., Hersey, P., Dummer, R., Khattak, M.A., Millward, M., Patel, S.P., Haydon, A., Johnson, D.B., Lo, S., Blank, C.U., Sandhu, S., Carlino, M.S., Larkin, J.M.G., Menzies, A.M., Long, G.V.
Published in Annals of oncology (01.08.2020)
Published in Annals of oncology (01.08.2020)
Get full text
Journal Article
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers
Trebeschi, S., Drago, S.G., Birkbak, N.J., Kurilova, I., Cǎlin, A.M., Delli Pizzi, A., Lalezari, F., Lambregts, D.M.J., Rohaan, M.W., Parmar, C., Rozeman, E.A., Hartemink, K.J., Swanton, C., Haanen, J B A G, Blank, C.U., Smit, E.F., Beets-Tan, R.G.H., Aerts, H.J.W.L
Published in Annals of oncology (01.06.2019)
Published in Annals of oncology (01.06.2019)
Get full text
Journal Article
Efficacy of TIL therapy in advanced cutaneous melanoma in the current immuno-oncology era: updated systematic review and meta-analysis
Martín-Lluesma, S., Svane, I.M., Dafni, U., Vervita, K., Karlis, D., Dimopoulou, G., Tsourti, Z., Rohaan, M.W., Haanen, J.B.A.G., Coukos, G.
Published in Annals of oncology (01.10.2024)
Published in Annals of oncology (01.10.2024)
Get full text
Journal Article
“One more chance to survive”: the experiences of patients with advanced melanoma and their partners with tumor-infiltrating lymphocyte therapy—a qualitative study and recommendations for future care
Egeler, M. D., Boomstra, E., Rohaan, M. W., Van den Heuvel, N. M. J., Fraterman, I., Delfos, M., van de Poll-Franse, L. V., Borch, T. H., Svane, I. M., Haanen, J. B. A. G., Retèl, V. P., Boekhout, A. H.
Published in Journal of cancer survivorship (22.08.2023)
Published in Journal of cancer survivorship (22.08.2023)
Get full text
Journal Article
Neoadjuvant cytoreductive treatment with BRAF/MEK inhibition of prior unresectable regionally advanced melanoma to allow complete surgical resection, REDUCTOR trial
Blankenstein, S., Rohaan, M.W., Klop, W.M.C., van der Hiel, B., van de Wiel, B., Peeper, D., van Akkooi, A.C.J., Haanen, J.B.A.G.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Clinical presentation of cardiac symptoms following treatment with tumor-infiltrating lymphocytes: diagnostic challenges and lessons learned
Borgers, J.S.W., van Schijndel, A.W., van Thienen, J.V., Klobuch, S., Seijkens, T.T.P., Tobin, R.P., van Heerebeek, L., Driessen-Waaijer, A., Rohaan, M.W., Haanen, J.B.A.G.
Published in ESMO open (01.02.2024)
Published in ESMO open (01.02.2024)
Get full text
Journal Article
Randomized phase III study comparing a non-myeloablative lymphocyte depleting regimen of chemotherapy followed by infusion of tumor infiltrating lymphocytes and interleukine-2 to standard ipilimumab treatment in metastatic melanoma
Rohaan, M.W., Borch, T.H., van den Berg, J.H., Geukes Foppen, M.H., Donia, M., Met, Ö, Nuijen, B., van Zon, M., Bakker, E.A.M., de Boer, R., Pronk, L.M., Wilgenhof, S., Blank, C.U., van Thienen, J.V., van Akkooi, A.C.J., Svane, I.-M., Haanen, J.B.A.G.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1254PNeoadjuvant cytoreductive treatment with BRAF/MEK inhibition of prior unresectable regionally advanced melanoma to allow complete surgical resection, REDUCTOR trial
Blankenstein, S, Rohaan, M W, Klop, W M C, van der Hiel, B, van de Wiel, B, Peeper, D, van Akkooi, A C J, Haanen, J B A G
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1184PDResults of a phase I trial with MART-1 T cell receptor modified T cells in patients with metastatic melanoma
Rohaan, M W, Gomez-Eerland, R, Foppen, M H Geukes, van Zon, M, de Boer, R, Bakker, N A M, Pronk, L M, Sari, A, Mallo, H A, van de Wiel, B A, Lalezari, F, Beijnen, J H, Nuijen, B, van Tinteren, H, van Thienen, J V, Blank, C U, Wilgenhof, S, Schumacher, T N, van den Berg, J H, Haanen, J B A G
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1303TiPRandomized phase III study comparing a non-myeloablative lymphocyte depleting regimen of chemotherapy followed by infusion of tumor infiltrating lymphocytes and interleukine-2 to standard ipilimumab treatment in metastatic melanoma
Rohaan, M W, Borch, T H, van den Berg, J H, Geukes Foppen, M H, Donia, M, Met, Ö, Nuijen, B, van Zon, M, Bakker, E A M, de Boer, R, Pronk, L M, Wilgenhof, S, Blank, C U, van Thienen, J V, van Akkooi, A C J, Svane, I-M, Haanen, J B A G
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial
Rohaan, M.W., Gomez-Eerland, R., van den Berg, J.H., Geukes Foppen, M.H., van Zon, M., Raud, B., Jedema, I., Scheij, S., de Boer, R., Bakker, N.A.M., van den Broek, D., Pronk, L.M., Grijpink-Ongering, L.G., Sari, A., Kessels, R., van den Haak, M., Mallo, H.A., Karger, M., van de Wiel, B.A., Zuur, C.L., Duinkerken, C.W., Lalezari, F., van Thienen, J.V., Wilgenhof, S., Blank, C.U., Beijnen, J.H., Nuijen, B., Schumacher, T.N., Haanen, J.B.A.G.
Published in Immuno-oncology technology (01.09.2022)
Published in Immuno-oncology technology (01.09.2022)
Get full text
Journal Article